Home/Filings/4/0001127602-21-013922
4//SEC Filing

WILSON DOW R 4

Accession 0001127602-21-013922

CIK 0000203527other

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 7:58 PM ET

Size

22.3 KB

Accession

0001127602-21-013922

Insider Transaction Report

Form 4
Period: 2020-11-05
WILSON DOW R
EVP and Pres. Oncology Sys.
Transactions
  • Disposition to Issuer

    Performance Shares

    2021-04-1523,5770 total
    Common Stock (23,577 underlying)
  • Disposition to Issuer

    Performance Stock Option

    2021-04-15$131.58/sh130,095$17,117,9000 total
    Exercise: $45.92Common Stock (130,095 underlying)
  • Disposition to Issuer

    Performance Shares

    2021-04-1520,7630 total
    Common Stock (20,763 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2021-04-1521,6130 total
    Common Stock (21,613 underlying)
  • Gift

    Common Stock

    2021-02-0815,46042,485 total
  • Disposition to Issuer

    Common Stock

    2021-04-1539,2310 total
  • Disposition to Issuer

    Performance Stock Option

    2021-04-15$118.76/sh163,361$19,400,7520 total
    Exercise: $58.74Common Stock (163,361 underlying)
  • Gift

    Common Stock

    2020-11-0546,70035,864 total
  • Gift

    Common Stock

    2021-02-223,39839,087 total
Footnotes (10)
  • [F1]Amount of securities beneficially owned at end of reporting period reflect 144 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan.
  • [F10]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.
  • [F2]Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
  • [F3]Each performance stock unit represents a contingent right to receive one share of VAR common stock.
  • [F4]Pursuant to the Merger Agreement, these performance stock units, which were granted November 16, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
  • [F5]Pursuant to the Merger Agreement, performance stock units, which were granted November 22, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
  • [F6]Each performance stock option represents a contingent right to purchase one share of VAR common stock at the derivative security price.
  • [F7]Pursuant to the Merger Agreement, these performance stock options, which were granted November 16, 2018, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
  • [F8]Pursuant to the Merger Agreement, these performance stock options, which were granted November 22, 2019, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
  • [F9]Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

Issuer

VARIAN MEDICAL SYSTEMS INC

CIK 0000203527

Entity typeother

Related Parties

1
  • filerCIK 0001313996

Filing Metadata

Form type
4
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 7:58 PM ET
Size
22.3 KB